197 related articles for article (PubMed ID: 17892140)
1. [CEOP regimen in the treatment for non-Hodgkin's lymphoma].
Huang HQ; Lin XB; Pan ZH; Bu Q; Gao Y; Wang BF; Cai QQ; Xia ZJ; Xu RH; Jiang WQ; Guan ZZ
Zhonghua Zhong Liu Za Zhi; 2007 May; 29(5):391-5. PubMed ID: 17892140
[TBL] [Abstract][Full Text] [Related]
2. Non-Hodgkin's lymphoma in the elderly: the impact of advanced age on therapeutic options and clinical results.
Orlandi E; Lazzarino M; Brusamolino E; Castelli G; Pagnucco G; Morra E; Bernasconi C
Haematologica; 1991; 76(3):204-8. PubMed ID: 1743590
[TBL] [Abstract][Full Text] [Related]
3. CEOP/PEB alternating chemotherapy in advanced intermediate and high-grade non-Hodgkin's lymphomas.
Abate G; Tafuto S; Romano A; Gailli E; Corazzelli G
Haematologica; 1992; 77(4):322-5. PubMed ID: 1385277
[TBL] [Abstract][Full Text] [Related]
4. [Cyclophosphamide-vincristine-prednisone combination in the treatment of lympho- and reticulosarcomas in adults (60 cases)].
Gorin NC; David R; Stachowiak J; Najman A; Duhamel G
Nouv Presse Med; 1976 Nov; 5(38):2525-30. PubMed ID: 790316
[TBL] [Abstract][Full Text] [Related]
5. [Combination chemotherapy with adriamycin, cyclophosphamide, vincristine, prednisolone (VEPA) in non-Hodgkin's lymphoma, with special reference to correlation of surface phenotype with response and survival].
Chubachi A; Miura AB; Yamaguchi A; Nishimura S
Gan To Kagaku Ryoho; 1988 Jul; 15(7):2057-63. PubMed ID: 3293535
[TBL] [Abstract][Full Text] [Related]
6. NOVP: a novel chemotherapeutic regimen with minimal toxicity for treatment of Hodgkin's disease.
Hagemeister FB; Cabanillas F; Velásquez WS; Meistrich ML; Liang JC; McLaughlin P; Redman JR; Romaguera JE; Rodríguez MA; Swan F
Semin Oncol; 1990 Dec; 17(6 Suppl 10):34-8; discussion 38-40. PubMed ID: 2259922
[TBL] [Abstract][Full Text] [Related]
7. Combination chemotherapy and radiotherapy in non-Hodgkin's lymphomata.
Bonadonna G; De Lena M; Lattuada A; Milani F; Monfardini S; Beretta G
Br J Cancer Suppl; 1975 Mar; 2():481-8. PubMed ID: 52367
[TBL] [Abstract][Full Text] [Related]
8. [Clinical significance of immunophenotype in diffuse non-Hodgkin's lymphoma: with special emphasis on the clinical characteristics of T-cell lymphoma].
Chubachi A; Miura AB; Takatsu H; Yamaguchi A; Nishimura S; Nakayama Y; Akihama T; Miura S; Saitoh M; Watanuki T
Gan To Kagaku Ryoho; 1991 Jul; 18(8):1303-9. PubMed ID: 2069401
[TBL] [Abstract][Full Text] [Related]
9. Aggressive non Hodgkin lymphoma in the elderly. A retrospective study of 72 patients with clinical features and treatment.
Brice P; Lepage E; Gisselbrecht C; Fior R; Trédaniel J; d'Agay MF; Boiron M
Nouv Rev Fr Hematol (1978); 1990; 32(2):153-7. PubMed ID: 2377447
[TBL] [Abstract][Full Text] [Related]
10. [Salvage therapy for recurrent or refractory non-Hodgkin's lymphoma with etoposide, methotrexate, vindesine and prednisolone (EMVP)].
Sano F; Koike M; Nakamura K; Wakayama T; Kunika N; Kubomatsu Y; Katoh M; Chisa M; Hasegawa S; Takahashi M
Gan To Kagaku Ryoho; 1992 Dec; 19(14):2389-93. PubMed ID: 1463345
[TBL] [Abstract][Full Text] [Related]
11. Advanced lymphocytic lymphoma: randomized comparisons of chemotherapy and radiotherapy, alone or in combination.
Young RC; Johnson RE; Canellos GP; Chabner BA; Brereton HD; Berard CW; DeVita VT
Cancer Treat Rep; 1977 Sep; 61(6):1153-9. PubMed ID: 332349
[TBL] [Abstract][Full Text] [Related]
12. [Chemotherapy of aggressive non-Hodgkin's lymphomas: a retrospective analysis of a single institution].
Ohnoshi T; Hayashi K; Ueno K; Murashima M; Tada A; Mizuta J; Tagawa S; Kimura I; Motoi M
Rinsho Ketsueki; 1989 Aug; 30(8):1201-4. PubMed ID: 2601033
[TBL] [Abstract][Full Text] [Related]
13. The influence of chemotherapy on the management of non-Hodgkin's lymphomata at the Princess Margaret Hospital. A comparison of the results from 1962-64 with 1967-69.
Bergsagel DE; Brown TC; Reid J
Br J Cancer Suppl; 1975 Mar; 2():489-96. PubMed ID: 1101934
[TBL] [Abstract][Full Text] [Related]
14. Results of combination chemotherapy of non-Hodgkin's lymphoma.
Schein PS; Chabner BA; Canellos GP; Young RD; Berard C; DeVita VT
Br J Cancer Suppl; 1975 Mar; 2():465-73. PubMed ID: 1101932
[TBL] [Abstract][Full Text] [Related]
15. Cyclophosphamide, epirubicin, vincristine and prednisone (CEOP) in the treatment of advanced stage non-Hodgkin's lymphomas with poor histology.
Comella P; Abate G; Fiore M; Di Finizio G; Polverino W; Muto P; Zarrilli D
Haematologica; 1988; 73(6):509-12. PubMed ID: 3148514
[No Abstract] [Full Text] [Related]
16. Non-Hodgkin's lymphoma of the elderly. Prognostic factors and outcome.
Rossini F; Mingozzi S; Pogliani EM; Pioltelli P; Lanzi E; Corneo G
Recenti Prog Med; 1991 May; 82(5):262-5. PubMed ID: 1887148
[TBL] [Abstract][Full Text] [Related]
17. Combination chemotherapy in non-Hodgkin's lymphoma: results of long-term followup.
Anderson T; Bender RA; Fisher RI; DeVita VT; Chabner BA; Berard CW; Norton L; Young RC
Cancer Treat Rep; 1977 Sep; 61(6):1057-66. PubMed ID: 71205
[No Abstract] [Full Text] [Related]
18. Surgery and chemotherapy in the treatment of gastric non-Hodgkin's lymphoma.
Rossini F; Pogliani EM; Pioltelli P; Lanzi E; Casaroli I; Bolis S; Corneo G
Recenti Prog Med; 1990 Jun; 81(6):448-52. PubMed ID: 2251455
[TBL] [Abstract][Full Text] [Related]
19. Non-Hodgkin's malignant lymphomata in adults: chemo-radiotherapy in stages III and IV.
Pouillart P; Hayat M; Schwarzenberg L; Amiel JL; Mathé G; Tubiana M
Br J Cancer Suppl; 1975 Mar; 2():505-11. PubMed ID: 52369
[TBL] [Abstract][Full Text] [Related]
20. Comparison of CHOP-B vs CEOP-B in 'poor prognosis' non-Hodgkin's lymphomas. A randomized trial.
De Lena M; Maiello E; Lorusso V; Brandi M; Calabrese P; Romito S; Mazzei A; Marzullo F
Med Oncol Tumor Pharmacother; 1989; 6(2):163-9. PubMed ID: 2473364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]